Skip to main content
SpringerLink
Log in

Seltene Erkrankungen an der Haut erkennen

Recognize rare diseases on the skin

  • Seltene Erkrankungen
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Die korrekte Interpretation von Hauterscheinungen kann die Diagnose zahlreicher seltener systemischer Erkrankungen erleichtern. Solchen Manifestationen können sowohl Autoimmunerkrankungen (Dermatomyositis, systemischer Lupus erythematodes, systemische Sklerodermie, Sarkoidose) als auch Stoffwechselerkrankungen (Porphyria cutanea tarda, Anderson-Fabry-Krankheit) zugrunde liegen. Andere Hauterscheinungen sind von großer Wichtigkeit, weil sie mögliche Warnzeichen okkulter Erkrankungen der inneren Organe sind. Dies gilt beispielsweise für einige Erkrankungen aus der Gruppe der neutrophilen Dermatosen (Pyoderma gangraenosum, Sweet-Syndrom).

Abstract

The correct interpretation of skin manifestations can facilitate the diagnosis of many rare systemic diseases. Such manifestations can be due to autoimmune diseases (e.g. dermatomyositis, systemic lupus erythematosus, systemic sclerosis and sarcoidosis) and metabolic diseases (e.g. Anderson-Fabry disease and porphyria cutanea tarda). Other cutaneous symptoms are of great importance because they are possible warning signs of occult diseases of internal organs. This is true for example for some diseases from the group of neutrophilic dermatoses, such as Sweet’s syndrome and pyoderma gangraenosum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9
Abb. 10

Literatur

  1. Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14(5):269–278

    Article  PubMed  Google Scholar 

  2. Marvi U, Chung L, Fiorentino DF (2012) Clinical presentation and evaluation of dermatomyositis. Indian J Dermatol 57(5):375–381

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zahr ZA, Baer AN (2011) Malignancy in myositis. Curr Rheumatol Rep 13:208–215

    Article  PubMed  Google Scholar 

  4. Kuhn A, Gensch K, Ständer S, Bonsmann G (2006) Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification. Hautarzt 57(3):251–267

    Article  CAS  PubMed  Google Scholar 

  5. Kuhn A, Landmann A (2014) The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun 48–49:14–19

    Article  PubMed  Google Scholar 

  6. Vanoni F, Lava SAG, Fossali EF et al (2017) Neonatal systemic lupus erythematosus syndrome: a comprehensive review. Clin Rev Allergy Immunol 53(3):469–476

    Article  CAS  PubMed  Google Scholar 

  7. Inzinger M, Salmhofer W, Binder B (2012) Neonatal lupus erythematosus and its clinical variability. J Dtsch Dermatol Ges 10(6):407–411

    PubMed  Google Scholar 

  8. Hasbún T, Chamlin SL (2014) A 6‑week-old boy with annular skin lesions. Neonatal lupus erythematosus. Pediatr Ann 43(1):e1–e3

    Article  PubMed  Google Scholar 

  9. Alavi A, Sajic D, Cerci FB et al (2014) Neutrophilic dermatoses: an update. Am J Clin Dermatol 15(5):413–423

    Article  PubMed  Google Scholar 

  10. Kridin K, Cohen AD, Amber KT (2018) Underlying systemic diseases in pyoderma gangrenosum: a systematic review and meta-analysis. Am J Clin Dermatol 19(4):479–487

    Article  PubMed  Google Scholar 

  11. Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE (2013) Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol 69(4):557–564

    Article  CAS  PubMed  Google Scholar 

  12. Grignano E, Jachiet V, Fenaux P et al (2018) Autoimmune manifestations associated with myelodysplastic syndromes. Ann Hematol 97(11):2015–2023. https://doi.org/10.1007/s00277-018-3472-9

    Article  CAS  PubMed  Google Scholar 

  13. Hindryckx P, Novak G, Costanzo A, Danese S (2017) Disease-related and drug-induced skin manifestations in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 11(3):203–214

    CAS  PubMed  Google Scholar 

  14. Tchernev G (2006) Cutaneous sarcoidosis: the „great imitator“: etiopathogenesis, morphology, differential diagnosis, and clinical management. Am J Clin Dermatol 7(6):375–382

    Article  PubMed  Google Scholar 

  15. Saltman AP, Kuriya B (2017) Löfgren syndrome in acute sarcoidosis. CMAJ 189(39):E1230

    Article  PubMed  PubMed Central  Google Scholar 

  16. Fernandez-Faith E, McDonnell J (2007) Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol 25(3):276–287

    Article  PubMed  Google Scholar 

  17. Simunovic C, Shinohara MM (2014) Complications of decorative tattoos: recognition and management. Am J Clin Dermatol 15(6):525–536

    Article  PubMed  Google Scholar 

  18. Cutolo M, Smith V, Furst DE, Khanna D, Herrick AL (2017) Points to consider-Raynaud’s phenomenon in systemic sclerosis. Rheumatology (Oxf) 56(suppl 5):v45–v48

    Article  CAS  Google Scholar 

  19. Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685–1699

    Article  PubMed  Google Scholar 

  20. Ferreli C, Gasparini G, Parodi A et al (2017) Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol 53(3):306–336

    Article  CAS  PubMed  Google Scholar 

  21. Sangle SR, D’Cruz DP (2015) Livedo reticularis: an enigma. Isr Med Assoc J 17(2):104–107

    PubMed  Google Scholar 

  22. Medlin JL, Hansen KE, Fitz SR, Bartels CM (2016) A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus. Semin Arthritis Rheum 45(6):691–697

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wu S, Xu Z, Liang H (2014) Sneddon’s syndrome: a comprehensive review of the literature. Orphanet J Rare Dis 9:215

    Article  PubMed  PubMed Central  Google Scholar 

  24. Shrikrishnapalasuriyar N, Noyvirt M, Evans P et al (2018) Livedo reticularis: a cutaneous clue to an underlying endocrine crisis. Endocrinol Diabetes Metab Case Rep. https://doi.org/10.1530/edm-17-0170

    Article  PubMed  PubMed Central  Google Scholar 

  25. Vasudevan B, Verma R, Pragasam V, Badad A (2014) Livedo reticularis due to pellagra in a two year old child. Indian J Dermatol 59(3):317

    Article  PubMed  PubMed Central  Google Scholar 

  26. Quaresma MV, Gomes AC, Serruya A et al (2015) Amantadine-induced livedo reticularis—case report. An Bras Dermatol 90(5):745–747

    Article  PubMed  PubMed Central  Google Scholar 

  27. Thornsberry LA, LoSicco KI, English JC 3rd (2013) The skin and hypercoagulable states. J Am Acad Dermatol 69(3):450–462

    Article  PubMed  Google Scholar 

  28. Marzano AV, Vezzoli P, Berti E (2013) Skin involvement in cutaneous and systemic vasculitis. Autoimmun Rev 12(4):467–476

    Article  PubMed  Google Scholar 

  29. Kerk N, Goerge T (2013) Livedoid vasculopathy—a thrombotic disease. Vasa 42(5):317–322

    Article  PubMed  Google Scholar 

  30. Tuttolomondo A, Pecoraro R, Simonetta I et al (2013) Anderson-Fabry disease: a multiorgan disease. Curr Pharm Des 19(33):5974–5996

    Article  CAS  PubMed  Google Scholar 

  31. Giuseppe P, Daniele R, Rita BM (2013) Cutaneous complications of Anderson-Fabry disease. Curr Pharm Des 19(33):6031–6036

    Article  PubMed  Google Scholar 

  32. Bissell DM, Anderson KE, Bonkovsky HL (2017) Porphyria. N Engl J Med 377(9):862–872

    Article  CAS  PubMed  Google Scholar 

  33. Kranzelbinder B, Wiednig M, El-Shabrawi-Caelen L, Aberer W, Aberer E (2015) Sclerodermiform porphyria cutanea tarda after torasemide. Eur J Dermatol 25(5):484–485

    CAS  PubMed  Google Scholar 

  34. Handler NS, Handler MZ, Stephany MP, Handler GA, Schwartz RA (2017) Porphyria cutanea tarda: an intriguing genetic disease and marker. Int J Dermatol 56(6):e106–e117

    Article  PubMed  Google Scholar 

  35. Markova A, Lester J, Wang J, Robinson-Bostom L (2012) Diagnosis of common dermopathies in dialysis patients: a review and update. Semin Dial 25(4):408–418

    Article  PubMed  Google Scholar 

  36. Guiotoku MM, Pereira Fde P, Miot HA, Marques ME (2011) Pseudoporphyria induced by dialysis treated with oral N‑acetylcysteine. An Bras Dermatol 86(2):383–385

    Article  PubMed  Google Scholar 

  37. Conde Fernandes I, Sanches M, Velho G et al (2011) Scleromyxedema vs scleredema: a diagnostic challenge. Eur J Dermatol 21(5):822–823

    PubMed  Google Scholar 

  38. Kreuter A (2018) Scleredema adultorum: clinical presentation, diagnostic workup, differential diagnosis, treatment option. Hautarzt. https://doi.org/10.1007/s00105-018-4259-6

    Article  PubMed  Google Scholar 

  39. Cron RQ, Swetter SM (1994) Scleredema revisited. A poststreptococcal complication. Clin Pediatr (Phila). https://doi.org/10.1177/000992289403301006

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Dermatologie und Allergologie, Universitätsklinikum Marburg (UKGM), Baldingerstr. 1, 35043, Marburg, Deutschland

    Bruno Gualtieri &  Michael Hertl

Authors
  1. Bruno Gualtieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Hertl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruno Gualtieri.

Ethics declarations

Interessenkonflikt

B. Gualtieri und M. Hertl geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

Additional information

Redaktion

J.R. Schäfer, Marburg

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gualtieri, B., Hertl, M. Seltene Erkrankungen an der Haut erkennen. Internist 60, 193–201 (2019). https://doi.org/10.1007/s00108-018-0548-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-018-0548-5

Schlüsselwörter

Keywords

Search

Navigation